Dren Bio
PrivateLast Round
Corporate Funding
Jul 24, 2024
Total Funding Raised
$156M
Company Overview
Dren Bio is a biotechnology company that develops therapeutic antibodies designed to selectively target and deplete pathogenic cells and disease-causing agents for the treatment of cancer, autoimmune disorders, and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dren Bio Comparables
Compare Dren Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UCB | 85% | |
| Abcuro | 84% | |
| Zenas BioPharma | 77% |
Dren Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 24, 2024 | ||||
| Series B | Jun 14, 2022 | ||||
| Series A | Oct 16, 2020 | ||||
| Seed | Jul 1, 2019 |
Dren Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiho Ventures | Series B, Series A |
| ArrowMark Partners | Series B |
| HBM Healthcare Investments | Series A, Series B |
| BVF Partners L.P. | Series B, Series A |
| Alexandria Venture Investments | Series B, Series A |
| Aisling Capital | Series B |
| 8VC | Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Launched proprietary platform for developing multispecific antibodies.
- Apr 1, 2026
Lead candidate dibotatug (DR-01) is in clinical development.
Dren Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dren Bio's valuation, stock price, and market status.
Is Dren Bio a public or private company?
Dren Bio is a private company.
What is the current stock price of Dren Bio?
Dren Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Dren Bio worth (valuation)?
Valuation information for Dren Bio is not publicly available.
Can I buy Dren Bio stock?
Dren Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Dren Bio's last funding round?
Dren Bio's most recent funding round was Strategic on July 24, 2024.
Who are the main investors in Dren Bio?
Key investors in Dren Bio include HBM Healthcare Investments, Aisling Capital, 8VC, SR One.
Will Dren Bio IPO soon?
No public IPO plans have been announced for Dren Bio.
How can I track Dren Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dren Bio's secondary market activity and sign up for updates.